357 Results (Page 11 of 15)
Singapore Markets Research Reports
Singapore ENT Devices Market Analysis
Singapore ENT Devices Market is projected to grow from $30 Mn in 2022 to $50 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Singapore ENT devices market include STAR Institute of Microelectronics, Clarion Medical Technologies, and Clariti Medical.
Singapore Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Singapore Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.
Singapore Diabetes Devices Market Analysis
Singapore Diabetes Devices Market is expected to grow from $27 Mn in 2022 to $50 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-30. An increase in the number of cases of diabetes, a shift in urbanization, and an increase in sedentary lifestyles are the main factors propelling the Singapore diabetes devices market. The market is segmented by type and by the end user. Some key players in this market include Everlife, Forefront Medical Technology, KroniKare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
Singapore Coronary Stents Market Analysis
Singapore Coronary Stents Market is expected to grow from $14 Mn in 2022 to $21 Mn in 2030 with a CAGR of 5.35% for the forecasted year 2022-30. The demand for coronary stents in Singapore is being driven by the increased frequency of cardiovascular disorders such as coronary artery disease and hypertension. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Biosensors International Group, Structo, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
Singapore Contraceptive Devices Market Analysis
Singapore's Contraceptive Devices Market is expected to grow from $15 Mn in 2022 to $30 Mn in 2030 with a CAGR of 8.60% for the forecasted year 2022-30. In Singapore, the use of contemporary contraceptive techniques such as hormonal contraceptives and LARCs has been rising. This pattern is predicted to persist, creating a growing opportunity for producers of cutting-edge contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Biosensors International, Everlife, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Singapore Cancer Immunotherapy Market Analysis
Singapore's cancer immunotherapy market is expected to grow from $135 Mn in 2022 to $244 Mn in 2030 with a CAGR of 7.7% for the forecasted year 2022-30. The increased demand for personalized medicine for treatment and rising investments in the research and development of immunotherapy in Singapore is responsible for expanding the market. The Singapore cancer immunotherapy market is segmented by type, application, and end user. Invitrocue, Lion TCR, and AstraZeneca are the major players in the Singapore cancer immunotherapy market.
Singapore Anti Aging Therapeutics Market Analysis
Singapore's anti-aging therapeutics market is projected to grow from $1 Mn in 2022 to $3 Mn in 2030 with a CAGR of 17.13% for 2022-30. The rising geriatric population and supportive government policies in Singapore are driving the expansion of the market. The Singapore anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key competitors in the market are Coformula, UpperMed, and Shiseido.
Singapore Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of the Singapore Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
Singapore Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Singapore Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore Acne Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Singapore ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Singapore ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy, and expert insights.
Singapore 3D Imaging Market Analysis
Singapore's 3D imaging market is projected to grow from $0.04 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by a well-developed healthcare system and a strong emphasis on medical research and innovation. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
Singapore Over The Counter (OTC) Pharmaceuticals Market Analysis
Singapore's over-the-counter (OTC) pharmaceuticals market size was valued at $165 Mn in 2022 and is estimated to expand at a CAGR of 5.89% from 2022 to 2030 and will reach $260.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Singapore ePharmacy Market Analysis
This report presents a strategic analysis of the Singapore ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore ePharmacy Market, offering unmatched value, accuracy, and expert insights.
Singapore eHealth Market Analysis
This report presents a strategic analysis of the Singapore eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Singapore eHealth Market, offering unmatched value, accuracy, and expert insights.
Singapore Radiotherapy Market Analysis
By 2030, it is anticipated that the Singapore Radiotherapy Market will reach a value of $xx Mn from $8 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Singapore is dominated by a few domestic players such as Innopharmax Technologies, Hicom-Teck, and VHMED. The radiotherapy market in Singapore is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Singapore Radiotherapy is increasing on account of the rise in cancer cases in the country.
Singapore Liver Diseases Therapeutics Market Analysis
By 2030, the Singapore Liver Disease Therapeutics market is anticipated to reach a value of $45 Mn from $28 Mn in 2022, growing at a CAGR of 6.3% during 2022-30. Liver Disease Therapeutics in Singapore is dominated by a few domestic pharmaceutical companies such as Gastro-Enterology & Education, Pharmaforte, and AsiaPharm. The Liver Disease Therapeutics market in Singapore is segmented into different types of disease and different therapy types. Some of the major factors affecting the Singapore Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Singapore Diabetes Therapeutics Market Analysis
Singapore's diabetes therapeutics market is expected to witness growth from $173 Mn in 2022 to $378 Mn in 2030 with a CAGR of 10.3% for the forecasted year 2022-30. The increase in urbanization in Singapore is responsible for the rise in diabetes prevalence which acts as a main growth driver for the market. Initiatives like the War on Diabetes by the Singapore government are also leading to market development. The Singapore diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Sphaera Pharma, Pharmaxcels, and AstraZeneca are the major players in the Singapore diabetes therapeutics market.
Singapore Pharmaceutical Market Analysis
This report presents a strategic analysis of the Singapore Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Singapore Cardiovascular Diseases Therapeutics Market Analysis
Singapore's cardiovascular disease therapeutics market is expected to witness growth from $195 Mn in 2022 to $356 Mn in 2030 with a CAGR of 7.82% for the forecasted year 2022-30. due to the rising prevalence of cardiovascular diseases in Singapore along with the increase in demand for novel therapeutic options for treatment are the major market drivers for the market. The Singapore cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. iNova Pharmaceuticals, Eshcol Pharmaceutical, and Zydus are the major players in the Singapore cardiovascular disease therapeutics market.
Singapore ECG Equipments Market Analysis
Singapore ECG Equipment Market is expected to witness growth from $11 Mn in 2022 to $20 Mn in 2030 with a CAGR of 7.90% for the forecasted year 2022-30. The convenience, usability, and portability of portable and wireless ECG devices are driving up demand in Singapore. With the help of this equipment, patients may keep an eye on their heart health at home and send the information to clinicians for evaluation and therapy. It is anticipated that this tendency would increase demand for the producers of ECG equipment that provide such devices. The market is segmented by product type and by the end user. Some key players in this market include Biosensors International, Inzign Pte, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Singapore Digital Health Market Analysis
Singapore's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR xx% during the forecast period of 2022-2030. The market will be driven by the collaboration amongst healthcare stakeholders across the ecosystem to address people's expectations, Efficient and low-cost digital technologies. The market is segmented by solution, by deployment & by end-use. Some of the major players include Doctor Anywhere, Holmusk & Biofourmis Inc.
Singapore Oncology Drugs Market Analysis
Singapore's oncology market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market has been increasing over the past few decades, with the highest incidence rates. The market is segmented by drug class, therapy, indication, dosage form, and distribution channel. The key companies in the Singapore oncology drugs market are AstraZeneca, Raffles Medical Group, Wave Life Sciences, Sphaera Pharma, MSD Singapore, and others.
Singapore Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Singapore Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Singapore Physiotherapy Market Analysis
Physiotherapy is widely available in Singapore and is covered by most insurance plans due to which the Singapore physiotherapy market is expected to grow with a market size of about $64 Mn to $101 Mn with a CAGR of 5.85% for the period 2022-2030. As the population ages and the prevalence of chronic conditions increases, more will be growth in the physiotherapy market in Singapore. The market is segmented by equipment, application, and by service type. Some of the major companies in the Singapore physiotherapy market are BTL, DJO Global, and Enraf-Nonius.
Singapore Dental Care Market Analysis
Singapore's dental care services market size is at around $43.06 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. This report by Inisghts10 is segmented by treatment type, age group, and by clinical setup, and demography. With rapidly changing demographics and new opportunities like technological advancement in the field of orthodontics, veneers, and implants key players like National Dental Centre Singapore, Singapore Dental Corporation, and Q & M Dental Group are making major strides in the domain of dental care services.